Search research articles
Contact Us
Filters
Showing results (41-50 of 137) with videos related to
Page
of 14
Sort By:
Antimicrobial Agents and Chemotherapy
|
May 1, 1996
Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model
D M Cappelletty, M J Rybak
Expert Opinion on Emerging Drugs
|
July 2, 2005
Oxazolidinones: new players in the battle against multi-resistant Gram-positive bacteria
G W Kaatz, M J Rybak
Drug Intelligence & Clinical Pharmacy
|
September 1, 1982
Antimicrobial susceptibility tests
S A Hunt, M J Rybak
Clinical Pharmacy
|
November 1, 1984
Antihypertensive agents and hyperlipidemia
L M Gutschi, M J Rybak
Antimicrobial Agents and Chemotherapy
|
April 19, 2000
Activities of trovafloxacin and ampicillin-sulbactam alone or in combination versus three strains of vancomycin- intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model
J R Aeschlimann, E Hershberger, M J Rybak
The Annals of Pharmacotherapy
|
January 1, 1992
Intravitreal ganciclovir for cytomegalovirus retinitis in AIDS patients
W R Melchior, V Bindlish, M J Rybak
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 1, 1996
Stability and antimicrobial activity of gentamicin sulfate, tobramycin sulfate and amikacin sulfate in polypropylene syringes for use in once-daily aminoglycoside therapy
B Mitrzyk, P E Jarco, M J Rybak
Antimicrobial Agents and Chemotherapy
|
August 3, 1999
Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus
J R Aeschlimann, E Hershberger, M J Rybak
DICP : the Annals of Pharmacotherapy
|
May 1, 1990
Cefixime
N J Leggett, C Caravaggio, M J Rybak
Pharmacotherapy
|
February 24, 2001
Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam
T K Jellison, P S Mckinnon, M J Rybak
Page
of 14
Search research articles
Search
Showing results (41-50 of 137) with videos related to
Sort By:
Page
of 14
Antimicrobial Agents and Chemotherapy
|
May 1, 1996
Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model
D M Cappelletty, M J Rybak
Expert Opinion on Emerging Drugs
|
July 2, 2005
Oxazolidinones: new players in the battle against multi-resistant Gram-positive bacteria
G W Kaatz, M J Rybak
Drug Intelligence & Clinical Pharmacy
|
September 1, 1982
Antimicrobial susceptibility tests
S A Hunt, M J Rybak
Clinical Pharmacy
|
November 1, 1984
Antihypertensive agents and hyperlipidemia
L M Gutschi, M J Rybak
Antimicrobial Agents and Chemotherapy
|
April 19, 2000
Activities of trovafloxacin and ampicillin-sulbactam alone or in combination versus three strains of vancomycin- intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model
J R Aeschlimann, E Hershberger, M J Rybak
The Annals of Pharmacotherapy
|
January 1, 1992
Intravitreal ganciclovir for cytomegalovirus retinitis in AIDS patients
W R Melchior, V Bindlish, M J Rybak
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
December 1, 1996
Stability and antimicrobial activity of gentamicin sulfate, tobramycin sulfate and amikacin sulfate in polypropylene syringes for use in once-daily aminoglycoside therapy
B Mitrzyk, P E Jarco, M J Rybak
Antimicrobial Agents and Chemotherapy
|
August 3, 1999
Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureus
J R Aeschlimann, E Hershberger, M J Rybak
DICP : the Annals of Pharmacotherapy
|
May 1, 1990
Cefixime
N J Leggett, C Caravaggio, M J Rybak
Pharmacotherapy
|
February 24, 2001
Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam
T K Jellison, P S Mckinnon, M J Rybak
Page
of 14